Thursday, September 17, 2026

Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing

ZUG, Switzerland - Wednesday, 16. September 2026


    Positive topline results showed that Restylane Volyme (known as Restylane Contour in the U.S.) was highly effective in the correction of moderate-to-severe temple hollowing, with high responder rates maintained through Month 121
    Restylane Volyme was well tolerated, with no incidences of granulomas. Patient and investigator satisfaction were also high1
    These data support Galderma’s aim to expand the availability of the Restylane portfolio in China – a market undergoing significant expansion, and further strengthen Restylane’s vast clinical evidence base2,3

 

(BUSINESS WIRE)--Galderma (SIX: GALD) today announced positive topline results from a study of Restylane Volyme for the correction of moderate-to-severe temple hollowing in 162 patients in China.1 The study met its primary endpoint, demonstrating the effectiveness and safety of Restylane Volyme versus a no-treatment control, while also achieving high patient and investigator satisfaction.1 These data further reinforce Galderma's ambition to expand its Restylane hyaluronic acid (HA) injectables portfolio in China, one of the world's fastest-growing aesthetics markets, through evidence generation that supports broader patient access and additional treatment areas.1-3

Powered by diverse NASHA®, NASHA HD™, and OBT™ technologies, Restylane offers gels with the highest firmness to the highest flexibility, enabling personalized treatments that deliver structural support, natural-looking results, and a healthy glow.1,4-8 Restylane Volyme is a moderately soft and flexible gel made with OBT that distributes within the tissue to offer natural-looking results, helping to soften temple hollowing, restore facial balance, and create a refreshed appearance.1,4,9 With a dual-layer patent-pending technique leveraging both needle and cannula, Restylane Volyme enables healthcare professionals to provide precise, customized, and safe product placement in line with each patient’s aesthetic goals10-12

The volume of the temples can diminish with age, which can disrupt facial balance and harmony, and contribute to a tired, sunken, and aged appearance.12-14 These facial changes can be accelerated in people undergoing medication-driven weight loss, a phenomenon which has increased rapidly in recent years.12-14 Following the launch of Restylane Volyme in China for the treatment of the mid-face region, this study provides new evidence supporting its effectiveness and safety for correction of temple hollowing, in a market where there are currently limited options.1

“Temple hollowing is a common concern among patients seeking facial rejuvenation, particularly for those experiencing medication-driven weight loss, yet treatment options in China remain limited. These results demonstrate that Restylane Volyme can provide effective, natural-looking correction with high levels of patient satisfaction and a robust safety profile. As demand for individualized aesthetic treatments continues to grow in China, expanding the range of evidence-based solutions available will be increasingly important.”

PROF. ZHAO HONGYI
STUDY PRINCIPAL INVESTIGATOR,
DIRECTOR & CHIEF OF THE DEPARTMENT OF PLASTIC SURGERY, BEIJING HOSPITAL, CHINA

In this randomized, evaluator-blinded study, 162 adults were recruited across six sites in China and were split 2:1 into two groups; the Restylane Volyme treatment group or the no treatment control group.1 Results showed that for patients in the Restylane Volyme group:

    Strong effectiveness
        94.4% of patients demonstrated at least 1-grade improvement in temple hollowing, from baseline, in both temples at Month 6 after last treatment, compared to just 2.0% in the control group at Month 6 after baseline.1
        Blinded-evaluator Galderma Temple Volume Deficit Scale responder rates remained high through Month 121
        91.3% of patients showed improvement on the Global Aesthetic Improvement Scale for both temples through Month 12, according to the treating investigator1
    High satisfaction
        Patient satisfaction was high at Month 3 and remained consistently high, with more than 84% of patients satisfied with both the natural look and natural feel of their temples through Month 121
        More than 90% said they would recommend the treatment to a friend, and over 86% would have the treatment again1
        Half of the participants felt comfortable returning to social engagement within 24 hours after initial treatment1
    Robust safety
        Restylane Volyme was generally well tolerated, with no treatment-related serious adverse events and no granulomas1

“These positive topline results further strengthen the clinical evidence supporting Restylane Volyme and mark an important step in our strategy to expand the Restylane portfolio in China. As one of the world’s fastest-growing aesthetics markets, China presents a significant opportunity to address evolving patient needs with science-backed, differentiated solutions. This study supports our ambition to broaden the indications available to practitioners and patients, while reinforcing Galderma’s leadership in Injectable Aesthetics through continued investment in innovation and clinical research.”

BALDO SCASSELLATI SFORZOLINI, M.D., PH.D.
GLOBAL HEAD OF R&D
GALDERMA

With over 30 years of innovation and more than 77 million treatments administered worldwide, the Restylane portfolio offers a versatile range of HA gels that remain highly relevant in responding to today’s most significant aesthetic trends and needs.15-16 China is one of the fastest growing aesthetics markets worldwide and HA fillers are among the top 10 most-sold aesthetics products.2,3 This study highlights Galderma’s commitment to expand the availability of its Restylane portfolio to more patients and practitioners in China and exemplifies its continuing expansion in a growing and strategically significant market.

About the Restylane portfolio
Restylane HA treatments are designed differently to go beyond volumizing for natural-looking results.17-19 Our HA is minimally modified and our innovative manufacturing process preserves its biocompatibility while creating individual products designed for a specific purpose.5,20,21 Powered by NASHA®, NASHA HD™, and OBT™ technologies, Restylane offers gels with the highest firmness to the highest flexibility, enabling personalized treatments that deliver structural support, natural-looking results, and a healthy glow.4,6-8 Trusted for almost three decades, our HA gels work in sync with your skin for 100% natural-looking results. 18,22,23 Approved indications vary by market.

About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

References

    Galderma. Data on file. 43CH2401
    Deloitte. China Aesthetic Medicine Outlook Report. Accessed September 2026. Available online.
    Grand View Horizon. China Aesthetic Medicine Market Size & Outlook, 2026-2033. Accessed September 2026. Available online
    Galderma. Data on file. MA-56724. 2023. Global rheology data (xStrain and G´ including Restylane SHAYPE).
    Galderma. Data on file. MA-58650. Degree of modification of HA fillers.
    Nikolis A, et al. Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion. J Drugs Dermatol. 2024;23(4):255–261. doi: 10.36849/JDD.8145.
    Öhrlund Å, et al. Differentiation of NASHA and OBT Hyaluronic Acid Gels According to Strength, Flexibility, and Associated Clinical Significance. J Drugs Dermatol. 2024;23(1):1332–1336. doi: 10.36849/JDD.7648.
    Belmontesi M, et al. Injectable Non-Animal Stabilized Hyaluronic Acid as a Skin Quality Booster: An Expert Panel Consensus. J Drugs Dermatol. 2018;17(1):83–88.
    Talarico S et al. High Patient Satisfaction of a Hyaluronic Acid Filler Producing Enduring Full-Facial Volume Restoration: An 18-Month Open Multicenter Study. Dermatol Surg. 2015;41(12):1361-9. doi: 10.1097/DSS.0000000000000549
    Restylane® Volyme. IFU. Available online. Accessed September 2026
    Galderma Laboratories, L.P. Data on file. MA-63365 Study Report. 2025
    Galderma. Data on file. Restylane Contour temple investigator closeout meeting executive summary. 2025
    Humphrey CD & Lawrence AC. Implications of Ozempic and other GLP-1 receptor agonists for facial plastic surgeons. Facial Plast Surg, 2023;39:719-73. doi: 10.1055/a-2148-6321
    Tay JQ. Ozempic face: A new challenge for facial plastic surgeons. JPRAS.2023;81-97-98. doi: 10.1016/j.bjps.2023.04.057
    Galderma. Data on file. MA-57232 [Updated]. 77 Million treated.
    Galderma. Data on file. MA-55607. Restylane® 27 years data publications analysis
    Restylane® EU Instructions for Use. July 2026.
    Di Gregorio C, et al. 25+ years of experience with the Restylane portfolio of injectable HA fillers for facial aesthetic treatment. E-poster presented at AMWC; March 27-29, 2024; Monaco.
    Galderma. Data on file. MA-48544 Subject satisfaction (GAIS) – NASHA and OBT Fillers. 2021.
    Kablik J, et al. Comparative physical properties of HA dermal fillers. Dermatol Surg. 2009; 35, 302–312. doi: 10.1111/j.1524-4725.2008.01046.x.
    Edsman K, et al. Gel properties of hyaluronic acid dermal fillers. Dermatol Surg. 2012;38:1170–1179. doi: 10.1111/j.1524-4725.2012.02472.x.
    Solish N, et al. Dynamics of hyaluronic acid fillers formulated to maintain natural facial expression. J Cosmet Dermatol. 2019;18(3):738-746. doi: 10.1111/jocd.12961.
    Philipp‐Dormston WG, et al. Perceived naturalness of facial expression after HA filler injection in nasolabial folds and lower face. J Cosmet Dermatol. 2020;19(7):1600-1606. doi: 10.1111/jocd.1320

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260915734207/en/

Permalink
https://www.aetoswire.com/en/news/1609202657354

Contacts

For further information:

Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50

Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62

Céline Buguet
Franchises and R&D Communications Director
celine.buguet@galderma.com
+41 76 249 90 87

Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12

Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43

Schneider Electric Concludes Innovation Summit Middle East & Africa, Highlights Energy Intelligence as the Next Phase of the Energy Transition


 Abu Dhabi, United Arab Emirates -

As AI, electrification and industrial expansion reshape energy demand across the Middle East and Africa, Schneider Electric today concluded Innovation Summit Middle East & Africa by positioning energy intelligence as the next phase of the energy transition - where infrastructure becomes more connected, resilient and software-defined.


Held at ADNEC in Abu Dhabi, the two-day summit convened over 2,500 attendees, including government leaders, industry analysts, customers, partners, students, and media, under the theme ‘Advancing Energy Tech to Power Intelligence and Resilience.’


Industry leaders explored how electrification, AI-ready data centers, cybersecurity, and digital innovation are reshaping energy systems. Day one featured keynotes from H. E. Abdullah bin Touq Al Marri, UAE Cabinet Member and Minister of Economy and Tourism, and Schneider Electric CEO Olivier Blum, in the presence of H.E. Marie Audouard, Ambassador Extraordinary and Plenipotentiary of the French Republic to the UAE. The summit also featured the launch of the Innovation Hub, the Data Cube, and Olivier Blum’s address on “The Era of Intelligence.”


“We’re entering an Era of Intelligence in which AI is becoming embedded in the physical economy. AI may be digital, but it runs on electricity and depends on the physical systems beneath it,” said Olivier Blum, CEO of Schneider Electric. “As an Energy Technology Partner, we help customers connect energy and operations through data, software, AI and automation, turning intelligence into action to improve performance, resilience and competitiveness. The scale of this shift is clear in the Middle East and Africa, where governments and businesses are investing in energy and digital infrastructure to support industrial transformation and long-term growth.”


The summit also featured the release of the company’s 2026 Industrial AI in CPG Study for the UAE, which found that 59% of UAE manufacturers expect transformational AI adoption by 2030, compared with 42.2% globally. Walid Sheta, President, MEA Zone, said, “As our region’s manufacturers move faster and more confidently on industrial AI than anywhere else, it’s our responsibility to make sure that confidence is well-founded. Cybersecurity, resilience, and return on AI investment are the concerns we hear about most often from customers, and rightly so.”


Schneider Electric reaffirmed its commitment to collaborating with governments, customers, and partners to accelerate intelligent, resilient energy infrastructure.



Permalink

https://www.aetoswire.com/en/news/1609202657358


Contacts

Press contact:


Mohammed Abdulla


mabdulla@apcoworldwide.com


www.se.com

Wednesday, September 16, 2026

Rubedo Life Sciences Announces Clinical Study to Treat Hair Loss with GPX4 Modulator RLS-1496, First Human Ex Vivo Evidence Demonstrates Robust Hair Follicle Growth

 MOUNTAIN VIEW, Calif. - Wednesday, 16. September 2026 AETOSWire  



AGA clinical trial to begin in Fall 2026 led by David Pariser, MD, FACP, FAAD, former President of the American Academy of Dermatology and Principal Investigator in more than 450 dermatology clinical trials

Rubedo’s RLS-1496, the first and only GPX4 modulator currently in clinical trials, demonstrates superior hair follicle restoration in human ex vivo androgenetic alopecia (AGA) model, matching or outperforming finasteride; findings consistent with dual SenoAdaptive mechanism that activates dormant hair follicle

 


(BUSINESS WIRE) -- Rubedo Life Sciences, Inc. (Rubedo) today announced a new clinical study of investigational RLS-1496 in patients with androgenetic alopecia (AGA), beginning October 2026, with initial data expected in the first half of 2027. The study marks the first-ever clinical evaluation of a GPX4 modulator in hair loss, extending the program that established RLS-1496 as the world’s first GPX4 modulator to enter human clinical trials of any kind.


RLS-1496 has already demonstrated efficacy in clinical trials for actinic keratoses and aging skin, and other skin conditions such as psoriasis and atopic dermatitis, generating novel human evidence demonstrating the dual SenoAdaptive mechanism that clears pathologic senescent cells and promotes a redox reset by modulating NRF2 pathways in stressed aged cells, including stem and progenitor cells. Ex vivo studies on a human hair follicles AGA model resulted in the restoration of hair follicle growth, as depicted in the image above.


In an independent ex vivo human AGA model — conducted using intact human hair follicles from male patients with AGA, challenged with dihydrotestosterone (DHT) to replicate the follicular miniaturization environment seen in AGA patients — RLS‑1496 demonstrated statistically and highly statistically significant increases in hair follicle elongation compared to vehicle control at 2 doses, respectively, with the highest dose showing a numerically greater trend in mean elongation than finasteride.


Hair follicle elongation at Day 6 was greater with RLS-1496 versus vehicle across all doses, with the strongest effect at the highest concentration — directionally outperforming standard-of-care finasteride


The pattern is consistent with rescue of the anagen (active growth) phase, when targeting senescent cells from the follicular niche allows stem cell reactivation from the dormant state and the follicle to resume its natural growth program


“The senescent cell biology underlying hair follicle aging is compelling, deeply consistent with what we have seen across our RLS-1496 program, and vastly underexplored as a therapeutic target,” said Rubedo Chief Executive Officer Frederick Beddingfield III, MD, PhD, FAAD. “For the first time, we are bringing a medicine into the clinic designed to clear the aged cells at the root of stem cell dormancy and follicular miniaturization. We are proud to do so in partnership with Dr. Pariser, and we are moving with the same urgency that made RLS-1496 the world’s first GPX4 modulator in human trials.”


AGA is the most prevalent form of hair loss globally, affecting approximately 50 million men and 30 million women in the U.S. alone; however, the treatment landscape has seen no genuinely new FDA-approved approaches in nearly 30 years.2 The global AGA market, valued at $3.2 billion in 2025 and projected to reach $6.8 billion by 2035, is defined by two therapies — minoxidil and finasteride — that slow the hormonal signals that cause hair follicles to progressively shrink and degenerate, a process known as follicular miniaturization. Follicular miniaturization is the biological hallmark of AGA, in which each successive growth cycle produces a thinner, shorter hair until the follicle can no longer produce visible hair. Neither therapy addresses the senescent — aged and dysfunctional — cells now understood to accumulate within the follicular niche and drive this miniaturization at the cellular level.3,4,5


Unlike existing therapies that target secondary hormonal causes of hair loss, RLS-1496 is designed to act on the primary cellular aging mechanism: the accumulation of senescent and stressed dermal papilla cells that actively suppress stem cells, follicular regeneration, and drive progressive miniaturization. By targeting these cells with selective elimination or functional restoration, depending on the cell state, RLS-1496, a first-in-class SenoAdaptive Drug, aims to remove the cellular brake on follicular regeneration itself.3,4,5,6


Rubedo Co-Founder and Chief Scientific Officer Marco Quarta, PhD, will present the ex vivo data, along with additional RLS-1496 data, at the 13th Annual Aging Research & Drug Discovery (ARDD) Meeting at Harvard University, October 1–3, 2026 — the world’s largest dedicated longevity science conference. The presentation marks the first time a GPX4 modulator program in hair loss will be presented at a major longevity science conference.


Dr. Quarta said, “RLS-1496 appears to act at several convergent points in the AGA disease cascade — where we believe it acts by clearing senescent cells, suppressing follicular regeneration, reducing inflammatory SASP signaling, while also modulating NRF2 pathways and activating Wnt/β-catenin pathways governing anagen re-entry. To our knowledge, no approved AGA therapy operates at this level of biology.”


Rubedo’s proprietary ALEMBIC™ spatial transcriptomics applied to patient hair follicle biopsies identified senescence markers and transcriptomic signals consistent with activation of the follicular regenerative cascade, including the expansion of hair follicle progenitors, and downregulation of key drivers of the follicle regression phase — providing human clinical evidence that RLS-1496’s effects on senescent cell biology extend to hair follicle tissue. In preclinical animal studies, RLS-1496 also achieved approximately 32% greater hair regrowth versus vehicle.1,6,7


“The preliminary data we have seen with RLS-1496 are scientifically intriguing and warranted clinical evaluation,” said Dr. Pariser, Professor of Dermatology at Eastern Virginia Medical School and Principal Investigator of Virginia Clinical Research, Inc., who will be leading the RLS-1496 hair loss clinical trial. “The senescence biology underlying AGA is increasingly well-supported in the published literature, and RLS-1496 represents a genuinely novel approach to it. I look forward to seeing what the data show in patients given the ongoing unmet need.”


About RLS-1496 and GPX4 Modulation


Rubedo’s lead candidate RLS-1496, being developed for topical and oral administration, is a first-in-class, disease-modifying GPX4 modulator selectively targeting pathologic senescent and other stressed, aging cells that drive chronic, age-dependent diseases. These include immunology and inflammation (I&I), dermatology and skin aging, hair loss, metabolic syndrome (obesity, diabetes, liver fibrosis), sarcopenia, and neurodegenerative disease.


In certain pathologic cells, aging is associated with an imbalance in GPX4. Modulation of GPX4 sensitizes cells to ferroptosis, which is a type of programmed cell death and is believed to be an Achilles heel of senescent cells. By modulating GPX4 in ferroptosis-sensitive senescent “aged” cells, RLS-1496 may be able to clear these cells to fight disease and also support healthy cells to function properly and restore tissue homeostasis. Beyond its targeted senolytic function in triggering selective ferroptosis within pathological senescent cells, RLS-1496 can also act as a restorative modulator that induces a vital ‘redox-reset’ through a controlled hormetic response in stressed neighboring cells, effectively clearing the source of chronic inflammation while actively re-establishing healthy tissue homeostasis. This dual-action mechanism represents a novel drug category—Adaptive SenoTherapeutics.


RLS-1496 uses Rubedo’s proprietary, AI-driven drug discovery platform ALEMBIC™, which identifies targets within pathologic senescent cells and develops selective cellular rejuvenation medicines for these targets.


About Rubedo Life Sciences


Rubedo Life Sciences is a clinical-stage biotech developing a broad portfolio of innovative selective cellular rejuvenation medicines targeting aging cells that drive chronic age-related diseases. Our proprietary AI-driven ALEMBIC™ drug discovery platform is developing novel first-in-class small molecules to selectively target pathologic and senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic, and other chronic disorders, including hair loss. Our lead drug candidate – RLS-1496, a potential first-in-class disease-modifying GPX4 modulator – is currently in Phase I clinical trials. The Rubedo leadership team is composed of industry leaders and early pioneers in chemistry, AI technology, longevity science, and life sciences, with expertise in drug development and commercialization from both large pharmaceutical and leading biotechnology companies. The company is headquartered in Mountain View, CA, USA, and has offices in Milan, Italy. For additional information, visit www.rubedolife.com.


References


Rubedo Life Sciences. RLS-1496 demonstrates hair follicle elongation in a DHT-challenged ex vivo androgenetic alopecia model. Data on file. 2026.


Global Market Insights. Androgenetic Alopecia Treatment Market Size, Share & Trends Analysis Report. 2026


Bahta AW, Farjo N, Farjo B, Philpott MP. Premature Senescence of Balding Dermal Papilla Cells In Vitro Is Associated with p16(INK4a) Expression. Journal of Investigative Dermatology2008;128(5):1088-1094. doi: 10.1038/sj.jid.5701147


Yang YC, Fu HC, Wu CY, Wei KT, Huang KE, Kang HY. Androgen Receptor Accelerates Premature Senescence of Human Dermal Papilla Cells in Association with DNA Damage. PLoS ONE2013;8(11): e79434. doi: 10.1371/journal.pone.0079434


Upton JH, Hannen RF, Bahta AW, Farjo N, Farjo B, Philpott MP. Oxidative Stress-Associated Senescence in Dermal Papilla Cells of Men with Androgenetic Alopecia. Journal of Investigative Dermatology 2015;135(5):1244-1252. doi: 10.1038/jid.2015.28


Pappalardo A, Kim JY, Abaci HE, Christiano AM. Restoration of hair follicle inductive properties by depletion of senescent cells. Aging Cell2024;24: e14353. doi: 10.1111/acel.14353


Rubedo Life Sciences. RLS-1496 achieves 32% greater hair regrowth versus vehicle in preclinical animal studies. Data on file. 2026.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260916811892/en/



Permalink

https://www.aetoswire.com/en/news/1609202657361


Contacts

Investor Contact: Ali Siam, Chief Business Officer alisiam@rubedolife.com | 781-974-9559

Media Contact: Peter Collins, TogoRun p.collins@togorun.com | 908-499-1200

NetApp and Tampa Bay Buccaneers Partner to Enable Data-Driven Operational Excellence

 New sponsorship expands NetApp’s presence across the NFL, delivering trusted data, intelligence, and the ability to perform in critical moments


 


(BUSINESS WIRE)--NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced that they have been named an Official Partner of the Tampa Bay Buccaneers. This new relationship builds on NetApp’s status as the Official Intelligent Data Infrastructure Partner of the NFL, helping the league and its teams quickly and confidently access, manage, and activate their data. The Buccaneers will leverage NetApp technology to support the experience for Buccaneers fans in the stadium on game days and beyond.


“NetApp will serve as a trusted technology partner that will help us elevate the customer experience for all Buccaneers fans,” said Buccaneers Chief Commercial Officer Atul Khosla. “Reliable and secure access to data plays an essential role in the overall game day experience at Raymond James Stadium. NetApp’s industry-leading intelligent data infrastructure will help us deliver a more seamless and connected experience for our Krewe at games and across the digital platforms that we use.”


This partnership launches following the Buccaneers first regular 2026 season game against the Cincinnati Bengals on September 13. The partnership expands NetApp’s relationship with the NFL as the league’s Official Intelligent Data Infrastructure Partner, helping to securely manage, protect, and activate the data behind the league’s operations. Across the NFL, NetApp technology supports demanding real-world workloads, including the storage and availability of game day video used by NFL football operations and club football operations teams. This collaboration has demonstrated how the right infrastructure can help complex, data-intensive organizations operate more efficiently and resiliently.


By using NetApp Keystone, a flexible and simple subscription-based service that adapts to changing business needs, the Buccaneers can accelerate data workloads with industry-leading performance, intelligent data management, and high availability across data centers and cloud environments. The NetApp Platform delivers built-in data security that autonomously detects threats and enables rapid recovery.


“Successful teams achieve meaningful results long before game day by bringing together the right people, trusted data, sound decisions, and disciplined execution,” said Gabie Boko, Chief Marketing Officer at NetApp. “Elite sports show what organizations can accomplish when their people can turn information into confident action. As a Proud Partner of the Tampa Bay Buccaneers, we’re celebrating the preparation, trust, and teamwork that sustain excellence and the Intelligent Data Infrastructure that helps make it possible.”


Additional Resources


NetApp and the NFL Team Up with Intelligent Data Infrastructure

The Unseen MVP of the NFL Season

NetApp Named Presenting Partner of 2026 NFL Madrid Game

NetApp Data Platform Powers Data Operations for Super Bowl LX

About the Tampa Bay Buccaneers


The Tampa Bay Buccaneers are in their 51st season as members of the National Football League and compete in the National Football Conference’s South Division. They were purchased by the late Malcolm Glazer in 1995 and are currently owned by the Glazer Family. Established in 1976, the Buccaneers have totaled 10 division titles, two conference championships and two Super Bowl Championships, including Super Bowl LV that was played on their home field at Raymond James Stadium. The Buccaneers have also been leaders in the NFL in fan engagement, earning a record 12 consecutive No. 1 rankings in overall customer satisfaction in the league’s annual Voice of the Fan survey. Additionally, the franchise is very active in the community, with the Tampa Bay Buccaneers Foundation, the Glazer Vision Foundation and the Glazer Family Foundation. For more information, visit www.buccaneers.com.


About NetApp


For more than three decades, NetApp has helped the world’s leading organizations navigate change – from the rise of enterprise storage to the intelligent era defined by data and AI. Today, NetApp is the Intelligent Data Infrastructure company, helping customers turn data into a catalyst for innovation, resilience, and growth.


At the heart of that infrastructure is the NetApp data platform – the unified, enterprise-grade, intelligent foundation that connects, protects, and activates data across every cloud, workload, and environment. Built on the proven power of NetApp ONTAP, our leading data management software and OS, and enhanced by automation through the AI Data Engine and AFX, it delivers observability, resilience, and intelligence at scale.


Disaggregated by design, the NetApp data platform separates storage, services, and control so enterprises can modernize faster, scale efficiently, and innovate without lock-in. As the only enterprise storage platform natively embedded in the world’s largest clouds, it gives organizations the freedom to run any workload anywhere with consistent performance, governance, and protection.


With NetApp, data is always ready – ready to defend against threats, ready to power AI, and ready to drive the next breakthrough. That’s why the world’s most forward-thinking enterprises trust NetApp to turn intelligence into advantage.


Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.


NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260916768662/en/



Permalink

https://aetoswire.com/en/news/1609202657360


Contacts

Media Contact:  

Kenya Hayes  

NetApp  

kenya.hayes@netapp.com  


Investor Contact:  

Kris Newton  

NetApp  

kris.newton@netapp.com  


 

The Opening of Jayasom Wellness Resort Advancing AMAALA’s Wellness Vision


 RIYADH, Saudi Arabia - 

The latest addition to AMAALA’s wellness ecosystem integrates evidence-based practices with Arab and Eastern healing practices complemented by personalized wellness programs


 


(BUSINESS WIRE)--Red Sea Global (RSG), the regenerative tourism developer, has opened Jayasom Wellness Resort AMAALA, bringing a distinctive holistic health offering to the destination.


Designed by Heah & Co., with interiors by Studio Carter, Jayasom Wellness Resort AMAALA is located on Triple Bay’s largest cove and comprises 153 keys alongside 24 residences. The resort forms part of AMAALA’s secluded wellness core on the Red Sea coast, where nature and hospitality come together in a setting designed for reflection and renewal.


“As we launch the first Jayasom globally, we are bringing a new dimension to AMAALA’s wellness offering. Its dedicated, all-inclusive wellness retreats combine contemporary, evidence-based practices with Arab and Eastern healing traditions. Its personalized approach complements our ambition for AMAALA to become the world’s most comprehensive wellness destination supporting guests on their long-term health journeys in an exceptional natural environment,” said John Pagano, Group CEO of Red Sea Global.


The resort’s wellness philosophy brings together Arab and Eastern healing traditions alongside contemporary evidence-based practices, reflecting centuries of knowledge exchange across cultures, including contributions from pioneering scholars such as Ibn Sina (Avicenna). The offering spans holistic health, fitness, physiotherapy, nutrition, spa and beauty, supported by consultations, movement and daily activities. Each guest journey is tailored to individual goals including women’s health, couples and family wellbeing, as well as health, weight and lifestyle reset.


Nutrition is an integral part of the Jayasom Wellness Resort AMAALA experience, with a collection of eight dining venues designed to support balanced lifestyles. The resort's restaurants and cafés offer a diverse range of cuisines inspired by regional and international traditions, with an emphasis on fresh, seasonal ingredients and nutritious dishes. Complementing the dining offer are interactive culinary experiences and specialty concepts that encourage guests to explore the role of food in healthy living.


The resort is divided into an adults-only wellness offering and a dedicated experience for families. The adult-only zone provides a sanctuary focused on holistic therapies, physiotherapy, fitness and Pilates, while the family experiences feature age-specific facilities and activities designed to support connection, movement and healthy habits.


The Jayasom Residences comprise a limited collection of two- to four-bedroom beachfront villas, with private pools and expansive sea-facing terraces. Located adjacent to the resort, residents enjoy exclusive privileges such as complimentary wellness retreats, preferred access to treatments and dining, and invitations to Jayasom events worldwide.


Nestled between the Red Sea and the dramatic Tabuk mountains, the resort is surrounded by coastal landscapes providing opportunities for land and water-based activities. This includes hiking, trail running, cycling, kayaking, stand-up paddleboarding, snorkeling and diving.


Along with the rest of the destination, Jayasom Wellness Resort AMAALA is fully powered by solar energy. It also supports the destination’s ambition to achieve a 30% net conservation gain by 2040.


Jayasom AMAALA is the seventh resort to open at AMAALA, marking another milestone in the destination’s phased delivery. In the coming months, a further two resorts will join a growing portfolio of world-class hospitality brands, alongside branded residences, integrated wellness facilities, a marina, curated retail, a marine life experiential institute and destination dining.


About Red Sea Global


Red Sea Global (RSG) is a vertically integrated real estate developer with a diverse portfolio across tourism, residential, experiences, infrastructure, transport, healthcare, and services. This includes the luxury regenerative tourism destinations The Red Sea, which began welcoming guests in 2023, and AMAALA, which welcomed its first guests in 2026.


A third destination, Thuwal Private Retreat, opened in 2024. RSG was also entrusted with development works at AlWajh International Airport, focused on upgrading the terminal and infrastructure.


RSG is a PIF company and a cornerstone of Saudi Arabia’s ambition to diversify its economy. Across its growing portfolio of destinations, subsidiaries, and businesses, RSG seeks to lead the world toward a more sustainable future, showing how responsible development can uplift communities, drive economies, and enhance the environment.


About AMAALA


AMAALA is an unparalleled ultra-luxury wellness destination along the northwestern coast of the Red Sea in Saudi Arabia. Seamlessly blending sea, sun, sports, arts, and culture for an exceptional experience, it is one of the world’s most anticipated destinations developed by Red Sea Global (RSG) with regeneration at its core.


AMAALA officially opened its first resort in summer of 2026, with more than 1,600 hotel rooms set to open across nine different resorts complemented by high-end retail and fine dining experiences upon completion. The destination’s state-of-the-art wellness and spa facilities will offer a comprehensive array of multi-generational programs, services, and various therapies, customized by practitioners and centers pioneering in various medical and wellness fields for a more personalized wellness journey.


Influenced by AMAALA’s natural beauty and the purity of the Red Sea, the destination is where sustainability meets luxury. The aim of AMAALA is to offer the most comprehensive health and wellness experience that will help improve the wellbeing of its guests and community, helping them flourish and thrive.


Two of AMAALA’s hallmark features include Corallium Marine Life Institute, an educational and scientific research center, and the AMAALA Yacht Club, destined to become an international hub for luxury yachting.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260916231950/en/



Permalink

https://aetoswire.com/en/news/1609202657362


Contacts

For more information, please contact:

Arwa Alsantli, Manager - Public Relations

+966 56 616 6017

Arwa.Alsantli@RedSeaGlobal.com


 

iQmetrix to Deliver 2026 Telecom Industry Address and Product Announcements, Unveiling the Next Wave of Intelligent Commerce

  VANCOUVER, British Columbia - Tuesday, 15. September 2026 AETOSWire Print 




iQmetrix's annual industry briefing goes global on October 28, pairing a year of worldwide market intelligence with the company's outlook on AI-native commerce and a first look at what's next for its Intelligent Commerce Operating System


 


(BUSINESS WIRE)--iQmetrix, the global provider of Intelligent Commerce Operating Systems for telecom, today opened registration for the 2026 Telecom Industry Address and Product Announcements, taking place Wednesday, October 28, 2026. For the first time in the event's history, iQmetrix will run two dedicated virtual sessions: one built specifically for European audiences, alongside its long-running North American event. Both are free to attend.


Now in its seventh year, the Industry Address has become the telecom channel's annual checkpoint: an unfiltered read on where the market is heading, delivered by a company that sits at the intersection of telcos, retailers, and the partners who serve them. The 2026 edition draws on a year of research and direct conversations across international markets.


"We spend the year listening — to telcos, to retailers, to the partners building alongside us, in a dozen different markets," said Megan Howse, Senior Vice President, Marketing at iQmetrix. "The Telecom Industry Address is where all of that turns into something the industry can actually use. Adding a European session means we're no longer asking half our audience to take the North American view and translate it."


The 90-minute program runs in two parts. The first covers the trends, pressures, and openings shaping telecom commerce globally. The second is iQmetrix's annual product announcement, including an early look at what is coming next for the Intelligent Commerce Operating System — the category iQmetrix has defined around one orchestrated system connecting point of sale, ecommerce, inventory, activations, and customer journeys, with AI embedded in how the system runs rather than layered on top.


The event is open to the wider industry: telcos, retailers, repair providers, device and accessory manufacturers, distributors, industry media, and the broader telecom ecosystem. Attendees will leave with a clearer read on where the market is moving and practical direction for their commerce strategy in the year ahead.


Session details — Wednesday, October 28, 2026


Europe session: 1:00 p.m. UK / 2:00 p.m. CET / 9:00 a.m. ET / 7:00 a.m. MT

North America session: 12:00 p.m. ET / 10:00 a.m. MT / 9:00 a.m. PT / 5:00 p.m. CET

Both sessions cover the same content; attendees need only join the one that suits their schedule.


Registration is now open here. A recording will be sent to everyone who registers, whether or not they attend live.


About iQmetrix


iQmetrix is the global provider of Intelligent Commerce Operating Systems for telecom. It replaces fragmented legacy stacks with a modern, modular layer that orchestrates telcos, retailers, and OEMs into one intelligent flow across channels and markets. The result is less complexity, lower cost, and the speed to move ahead.


For 27years, iQmetrix has helped the leading brands in telecom grow by providing best-in-class software, services, and expertise. Its solutions powered $17 billion in sales last year, handling nearly 53 million invoices and more than 28 million activations, and are used by more than 370,000 telecom retail professionals across almost 1,000 clients. iQmetrix is a privately held software-as-a-service (SaaS) company with employees in Canada, the U.S., India, and Europe. For more information, visit www.iqmetrix.com.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260914992633/en/



Permalink

https://www.aetoswire.com/en/news/1509202657312


Contacts

Media Contact

media@iqmetrix.com

Chiesi Appoints David Khougazian as Group Chief Executive Officer to Lead the Next Phase of Innovation-Driven Growth


 PARMA, Italy -

Highlights:


David Khougazian appointed Group Chief Executive Officer to lead Chiesi's next phase of innovation-driven growth, effective 15 October 2026.

Bringing over 25 years of international healthcare leadership experience and a strong track record in innovation and transformation, David joins Chiesi from Flagship Pioneering.

 


(BUSINESS WIRE) -- Chiesi Group (Chiesi) today announced the appointment of David Khougazian as Group Chief Executive Officer (CEO), effective 15 October 2026.


David joins Chiesi following a distinguished international career spanning more than 25 years across the global healthcare and life sciences sectors. Most recently, he served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering, where he supported the growth and development of science-driven healthcare companies and worked closely with leadership teams on long-term value creation, partnerships, financing and organizational development.


Following a thorough selection process led by the Board of Directors, David will succeed Interim Group CEO Jean-Marc Bellemin, who has successfully led the Group since 15 May 2026, while also continuing in his permanent role as Group CFO.


Maria Paola Chiesi, Chiesi Group Chair, commented: “We are delighted to welcome David to Chiesi at a time of strong momentum for the company. Innovation has always been at the heart of Chiesi's mission and long-term vision. David's appointment reflects our ambition to accelerate this journey and strengthen Chiesi’s ability to innovate in a healthcare environment that is changing faster than ever. He brings a unique combination of global healthcare leadership, operational experience and exposure to some of the most dynamic areas of biotech innovation, which makes him exceptionally well positioned to guide Chiesi through this next chapter.

On behalf of the Board, I would like to express my sincere gratitude to Jean-Marc Bellemin for his commitment and stewardship during this transition period. I would also like to thank the entire Group Executive Leadership Team for their dedication and collective leadership, which have been instrumental in maintaining the Group's focus and preparing the organization for the next steps."


David Khougazian commented: “I am honored and excited to join Chiesi, a company widely recognized for its strong values, scientific excellence, entrepreneurial mindset and commitment to patients. The healthcare landscape is evolving rapidly, creating extraordinary opportunities to advance innovation and transform patient outcomes. Chiesi has built an impressive foundation, combining scientific expertise and a clear commitment to sustainable growth across generations.

I look forward to working alongside Chiesi colleagues around the world to further strengthen the Group's innovation capabilities, advance its pipeline and partnerships, and create lasting value for patients, healthcare systems and society.”


Chiesi remains firmly committed to executing its patient-centric strategy, advancing innovation across its therapeutic areas, and delivering sustainable growth for the benefit of patients, healthcare systems, communities and the planet.


About Chiesi Group

Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.

By adopting the legal form of Benefit Corporation in Italy, the US, France and Colombia, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, Chiesi meets verified standards for social and environmental business practices. The company aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035.

With 90 years of experience, Chiesi is headquartered in Parma (Italy), with 31 affiliates worldwide, and counts more than 7,900 employees. The Group’s research and development center in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.

For further information please visit www.chiesi.com or the website of your local Chiesi affiliate.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260915411388/en/



Permalink

https://www.aetoswire.com/en/news/1509202657328


Contacts

Press Info:

Anna Bonisoli Alquati, Head of Global External Communications: mediarelations@chiesi.com

Michela Lijoi, Global External Communications Sr. Manager: mobile +39 328.6353044, e-mail: m.lijoi@chiesi.com

Davide Paterlini, Global External Communications Sr. Manager: mobile +39 345.7983132, e-mail: d.paterlini@chiesi.com

AMAALA Yacht Club Opens, Putting the Red Sea on the Global Yachting Map

 Luxury sailing, wellness and exploration converge at Saudi Arabia's newest yachting destination


 


(BUSINESS WIRE)--Red Sea Global (RSG), the regenerative tourism developer, has announced that AMAALA Yacht Club has officially begun operations, marking a major milestone in establishing the Saudi Red Sea as a new global destination for luxury yachting, sailing and marine tourism.


Nestled within AMAALA Marina Village, the AMAALA Yacht Club is now welcoming founding members and visiting yachts to moor and explore the destination.


Located approximately 2,000 nautical miles from Monaco, the club provides a new winter destination for the world’s luxury sailing community, which traditionally migrates from the Mediterranean to the Caribbean or Indian Ocean from October. Positioned closer to the Mediterranean than the Caribbean, AMAALA offers an attractive winter cruising hub and a strategic gateway to the Indian Ocean.


“The AMAALA Yacht Club marks the emergence of a truly global yachting destination, offering unparalleled access to the stunning Saudi Red Sea coast. More than a world-class facility, it brings together luxury, wellness, and regenerative tourism in a way that is unique anywhere in the world,” said John Pagano, Group CEO of Red Sea Global.


AMAALA Marina features 119 berths, can accommodate superyachts of more than 100 meters and offers a comprehensive marine services, including fueling with maintenance and repair facilities in the coming years. The 7,900-square-meter AMAALA Yacht Club serves as a premier hub for the destination’s maritime community, offering world-class facilities, services and experiences for residents and visiting yacht owners alike. Berthing and mooring fees are comparable to leading European yachting destinations while yacht owners securing permanent moorings benefit from a range of exclusive privileges through selected resort partners.


Within AMAALA Yacht Club, members and guests can enjoy a selection of dining and social spaces, including AMAALA Lounge, ANQA, 27°C and The Deck, alongside a rooftop pool, private meeting suites and dedicated areas for social gatherings and events.


The AYC Academy will also offer sailing programs and watersports experiences, supporting participation at every level and across all age groups.


The club plays a key role in advancing Saudi Arabia’s presence on the global sailing stage. This includes being a centerpiece of the Grand Finale of The Ocean Race 2027, one of the world’s most prestigious sailing competitions. It will also host a series of international yachting events throughout the year.


The club’s members and guests will enjoy access to newly opened luxury resorts in AMAALA such as Four Seasons, Six Senses, Rosewood, Equinox, and Nammos with two additional resorts opening in the coming months. Visitors can revel in the elaborate wellness offerings, elite water sports, cultural programming, art installations and vibrant social spaces, creating a distinctive destination that reimagines the yachting lifestyle. With average temperatures of 26°C throughout the season and average lows of 23°C, AMAALA Offers a comfortable year-round cruising environment for yacht owners, guests and crew. Located just 45 minutes from Alwajh International Airport, the destination also provides convenient access and connectivity for international visitors.


Designed by HKS Architects, the yacht club draws inspiration from the sculpted rock formations of the Red Sea coastline, expressed through its cantilevered terraces, maritime heritage and traditional Arabian architectural forms. The landmark facility is designed to serve as long-term gathering place for the international sailing and yachting community.


Like the wider destination, AMAALA Yacht Club is powered entirely by renewable energy, reflecting Red Sea Global's commitment to responsible development and regenerative tourism.


About Red Sea Global


Red Sea Global (RSG) is a vertically integrated real estate developer with a diverse portfolio across tourism, residential, experiences, infrastructure, transport, healthcare, and services. This includes the luxury regenerative tourism destinations The Red Sea, which began welcoming guests in 2023, and AMAALA, which welcomed its first guests in 2026.


A third destination, Thuwal Private Retreat, opened in 2024. RSG was also entrusted with development works at AlWajh International Airport, focused on upgrading the terminal and infrastructure.


RSG is a PIF company and a cornerstone of Saudi Arabia’s ambition to diversify its economy. Across its growing portfolio of destinations, subsidiaries, and businesses, RSG seeks to lead the world toward a more sustainable future, showing how responsible development can uplift communities, drive economies, and enhance the environment.


About AMAALA Yacht Club


AMAALA Yacht Club is a new international hub for luxury yachting within AMAALA, the ultra-luxury wellness destination in the protected Prince Mohammed bin Salman Royal Reserve. Combining world-class marina infrastructure, contemporary design and exceptional hospitality, AMAALA Yacht Club serves as a gateway to the Red Sea, one of the world's most unexplored cruising grounds.


The 119-berth marina accommodates superyachts of more than 100 metres and offers a full international port of entry. Situated approximately 200 nautical miles south of the Suez Canal, the yacht club is ideally positioned for vessels looking to explore waters beyond the Mediterranean and Caribbean, while also providing an attractive winter base for both private and charter yachts.


Designed by internationally renowned architects HKS, the 7,900-square-metre clubhouse brings together elegant dining venues, private lounges, a pool deck and year-round programme of sailing and social events. AMAALA Yacht Club is also home to the AYC Academy, which delivers sailing programs for all ages and abilities, helping to inspire the next generation of sailors and establish the Red Sea as an emerging centre for sailing excellence.


AMAALA Yacht Club will host major international sailing events, including The Ocean Race in 2027, cementing its position as a new global hub for yachting and sailing in the Red Sea.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260914160771/en/



Permalink

https://www.aetoswire.com/en/news/1509202657310


Contacts

For more information, please contact:

Arwa Alsantli, Manager - Public Relations

+966 56 616 6017

Arwa.Alsantli@RedSeaGlobal.com

Workiva Advances Regulatory Work with AI Innovation


 LAS VEGAS -

Agent Studio anchors AI capabilities unveiled at Amplify 2026


(BUSINESS WIRE) -- Workiva Inc. (NYSE: WK), a leading, audit-ready platform for trust, transparency, and accountability, unveiled dozens of new product and platform innovations at Amplify 2026, the company’s annual conference attended by thousands of finance, accounting, sustainability, risk, and compliance leaders.


Workiva Debuts Agent Studio

Workiva introduced Agent Studio, a landmark platform capability that empowers users to quickly build, customize, and deploy AI agents in Workiva's trusted platform. By combining AI reasoning with Workiva's native platform capabilities, enterprise knowledge, and governed workflows, Agent Studio enables users to automate sophisticated manual business processes without writing any code. Organizations can enrich agents with company-specific knowledge and context, tailor them to their own processes, and schedule automations to execute recurring work.


“With Agent Studio, we're putting the power to build in the hands of the people who know the work and their company the best. But what you build is only as strong as what it's built on,” said Julie Iskow, CEO of Workiva. "Every company has access to AI. What matters is whether your outcomes are traceable, defensible, and can hold up in front of investors and regulators. This is even more important as AI becomes more ubiquitous."


Workiva Broadens Regulatory Reporting Footprint

The release of three new agentic solutions marks Workiva’s expansion into a wider universe of reporting obligations and regulatory work. Starting with what has historically been highly manual regulatory disclosures, such as BEA (Bureau of Economic Analysis) surveys, US Census surveys, and Country-by-Country Reporting, accounting and finance teams will be able to manage a broader range of regulatory requirements within the same connected platform.


Workiva Launches Automated Testing for Internal Audit and GRC

The new agentic solution accelerates testing while maintaining consistency, traceability, and governance. By orchestrating evidence, attribute, and testing agents, the solution replaces manual evidence collection, sample selection, attribute testing, and documentation with a purpose-built workflow that provides full traceability at every step. The result is expanded sampling capacity, broader risk coverage, and the ability to scale testing without scaling manual effort.


"Transformation requires genuine buy-in at every level of the value stream. This work has always demanded process precision. Now it demands velocity, too,” said Keri Tracy, Chief Audit Executive of Newell Brands. “As AI takes on more work, it frees audit professionals to focus on higher-value judgment, interpretation, and risk management. But that only works if people trust the technology. When teams feel heard, valued, and supported through the change, adoption follows naturally, controls strengthen, and the integrity of the process becomes the foundation that withstands any audit or regulatory scrutiny."


For more information about innovations announced at Amplify, visit workiva.com/platform/whats-new. Video demonstrations are available on the Workiva Demo Center, and Amplify attendees can experience them live in the Amplify hub.


About Workiva

Workiva Inc. (NYSE: WK) powers trust, transparency, and accountability. Finance, accounting, sustainability, risk, and audit teams from more than 6,700 organizations, including over 85% of Fortune 1,000 companies, rely on Workiva for their mission-critical work. Workiva transforms how customers connect data, unify processes, and empower teams in a secure, audit-ready platform. Learn more at workiva.com.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260915584662/en/



Permalink

https://aetoswire.com/en/news/1509202657344


Contacts

Media Contact:

Lauren Covello

Workiva Inc.

press@workiva.com


 

The Estée Lauder Companies Announces Partnership with Profound to Expand AI Visibility Across Its Global Brand Portfolio

 Partnership enables the company to lead prestige beauty's transition to AI-powered discovery while better understanding how consumers discover, evaluate, and engage with its brands across AI answer engines


 


(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) today announced a global strategic partnership with Profound, the category-defining AI marketing platform, advancing its ambition to be prestige beauty’s leader in AI-native discovery. The partnership will provide the company with visibility into how its full portfolio of brands is represented across leading generative AI platforms, as well as opportunities to optimize that representation. This partnership establishes the company as the first in prestige beauty to deploy Profound’s capabilities globally across the company’s full portfolio and operationalize Generative Engine Optimization (GEO) and AI marketing at scale.


As consumers increasingly turn to ChatGPT, Gemini, and other AI assistants to discover products, compare recommendations, and seek personalized beauty advice before a purchase, The Estée Lauder Companies is partnering with Profound to define the next era of beauty discovery.


This partnership will equip the company with a unified view of how its brands appear across major AI search platforms globally, providing insight into when and how they are recommended and where opportunities exist to improve visibility and accuracy. The company will then use these insights and Profound’s agentic tools to optimize content across brands’ product description pages, blogs, YouTube channels, and content creation at scale — ensuring product information, ingredients, claims, and benefits are optimized for consumer visibility and easier for large language models to understand and surface to consumers.


“The way people discover beauty is being rewritten in real time, and we intend to shape that shift rather than reacting to it,” said Aude Gandon, Global Chief Digital & Marketing Officer, The Estée Lauder Companies. “This partnership gives every brand in our portfolio the ability to show up distinctly, consistently, and accurately wherever our consumers are asking for recommendations. Our work with Profound is a natural extension of how we already think about culture, community, and commerce working together — and it puts us at the front of an industry-wide transition.”


“The Estée Lauder Companies recognizes that understanding how its brands are represented across AI is now essential to serving consumers wherever they choose to discover products and information,” said James Cadwallader, CEO and Co-founder, Profound. “Through this partnership, the company is now approaching GEO in the way the best marketers approach any platform shift: early, comprehensively, and with real operational commitment. Enabling this strategy at scale across an entire prestige beauty portfolio sets a new bar for what enterprise AI visibility strategy looks like in this category.”


By bringing enterprise-wide AI representation insights into its One Operating Ecosystem, The Estée Lauder Companies is strengthening its ability to understand how consumers encounter its brands across emerging digital touchpoints, respond to evolving needs, and deliver more relevant experiences across its global portfolio.


About The Estée Lauder Companies Inc.


The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products, and is a steward of luxury and prestige brands globally. The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary, NIOD, Avestan and Loopha, and Balmain Beauty.


About Profound


Profound is the fastest-growing AI marketing platform used by 16% of the Fortune 500, including Comcast and Walmart, and innovators like Ramp, MongoDB, and Figma. It is the workbench where marketers research, write, report, and collaborate with their AI Marketer to ensure their brand is chosen by the Answer Engines consumers increasingly rely on.


ELC-C


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260913741575/en/



Permalink

https://aetoswire.com/en/news/1509202657311


Contacts

Media Relations:

Brendan Riley

briley@estee.com


Investor Relations:

Rainey Mancini

rmancini@estee.com

The LYCRA Company Appoints Hua Du as Chief Executive Officer

 WILMINGTON, Del. - Tuesday, 15. September 2026



(BUSINESS WIRE) -- The LYCRA Company, a global leader in developing fiber and technology solutions for the apparel and personal care industries, announced today that Hua Du has been appointed chief executive officer, effective September 14, as the company enters its next chapter following the successful completion of its financial restructuring. Du succeeds Dean Williams, who served as interim chief executive officer and will continue in his role as chief financial officer.


Du brings 30 years of leadership experience in the specialty chemical and biotech-based industries, driving transformational growth across global businesses. Du most recently served as CEO of Grobest Group, a private equity-backed animal nutrition business, where he led a comprehensive operational turnaround culminating in the company's sale. Earlier in his career, he held senior leadership roles at Rhodia (later acquired by Solvay) and managed electronic materials businesses across Asia for Rohm and Haas, later acquired by Dow Chemical.


“We are pleased to welcome Hua as The LYCRA Company’s next CEO,” said Bruce Rubin, executive chairman of the company’s board of directors. “With his extensive technical expertise, operational leadership, and global customer focus, we are confident that Hua has the experience and vision to help shape a successful future for the business. On behalf of the board, I would like to thank Dean Williams for his leadership as interim CEO during this period of transition.”


“The LYCRA Company is built on a legacy of innovation, operational excellence, globally trusted brands, and deep expertise in fiber and materials science,” said Du. "I am honored to join this exceptional organization as we unlock new opportunities for innovation and growth.”


About The LYCRA Company


The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries and owns the leading consumer brands: LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX® and TACTEL®. Headquartered in Wilmington, Delaware, United States, The LYCRA Company is recognized worldwide for its high-quality products, technical expertise, and marketing support. The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. Learn more at thelycracompany.com.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260915565505/en/



Permalink

https://www.aetoswire.com/en/news/1509202657338


Contacts

Karie J. Ford

Karie.j.ford@lycra.com


 

Tuesday, September 15, 2026

QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases

 TORONTO - Tuesday, 15. September 2026 AETOSWire  


Multi-program collaboration leveraging QurCan’s TERP™ polymer-lipid nanoparticle delivery platform


Lilly to make a strategic investment in QurCan


(BUSINESS WIRE) -- QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle (PLNP) delivery of genetic medicines through its proprietary TERP™ (Target-Engineered Responsive Polymer) platform, today announced an exclusive research and collaboration agreement with Eli Lilly and Company (“Lilly”) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS).


Lilly and QurCan will collaborate on multiple research programs focused on the development of PLNP-enabled genetic medicine therapeutics for CNS and PNS delivery. Through this collaboration, QurCan will be responsible for optimizing genetic medicine therapeutics using its TERP platform, and Lilly will be responsible for further research, clinical development, and commercialization of the selected programs.


“This collaboration with Lilly represents a validation of our PLNP technology platform and its potential to address some of the most challenging delivery problems in genetic medicine,” said Mohammad Ali Amini, Chief Executive Officer of QurCan. “The CNS and PNS remain among the most underserved areas in genetic medicine delivery, and we believe our non-viral approach offers a differentiated and versatile solution across various nucleotide cargos. We are thrilled to work with Lilly, a company with unparalleled expertise in neuroscience drug development and commercialization, to bring these therapies to patients who urgently need them.”


Under the terms of the agreement, QurCan will receive an upfront payment as well as a strategic investment from Lilly. QurCan is eligible to receive research support payments together with research, development and commercial milestone payments up to US$237 million per program in addition to tiered royalties on global net sales of commercialized products.


ABOUT QURCAN THERAPEUTICS


QurCan Therapeutics is a Toronto-based biotechnology company developing next-generation genetic medicines for diseases of the central and peripheral nervous systems. QurCan’s proprietary TERP™ (Target-Engineered Responsive Polymer) platform enables repeat-dosable systemic and targeted polymer-lipid nanoparticle enabled delivery of mRNA, DNA, and oligonucleotide payloads to disease-relevant cell populations. For more information, visit www.qurcan.com.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260908631407/en/



Permalink

https://www.aetoswire.com/en/news/1509202657329


Contacts

QurCan Contact:

j.reid@qurcan.com

John Reid, CBO

Unifocus Launches AI-Powered Platform to Transform Workforce and Operations Management in Hospitality

   DALLAS - Tuesday, 15. September 2026 AETOSWire  



Combining enterprise-grade labor and operations technology on an AI-native platform, Unifocus Claira redefines workforce management and enables hospitality teams to make faster, more informed decisions.


 


(BUSINESS WIRE)--The global hospitality technology provider, Unifocus, has announced the launch of its newest AI platform, Unifocus Claira.


Unifocus Claira is an industry first end-to-end workforce management and operations platform, purpose-built to give hoteliers and above-property hospitality organizations complete visibility across the workforce lifecycle through one cohesive system.


By replacing the patchwork of disconnected tools, multiple technology stacks and siloed data systems that have traditionally been used to manage labor and operations processes, Unifocus Claira delivers one connected AI-native platform, providing customers with a comprehensive and organized view of their workforce and operations data. This unified data foundation powers advanced AI capabilities designed to accelerate decision-making, improve operational performance and drive business growth.


Importantly, Unifocus Claira is also the first end-to-end platform of its calibre, purpose-built specifically for the select service segment – a market that has historically been underserved by enterprise-grade workforce technology.


The platform delivers a complete view of labor and operations across forecasting, budgeting, scheduling, operational delivery, measurement and reporting in one platform:


Labor: Enhanced demand forecasting, zero-based budgeting, planning and scheduling, time and attendance.

Operations: Visibility across housekeeping, service, maintenance, inspection, and inventory.

Performance Insights: Advanced AI-powered labor and operations analytics that turns data into actionable insights

Ask Claira: A natural-language AI assistant tool delivers answers, recommendations, and takes action in real time.

Backed by Unifocus’ more than 25 years of deep industry expertise, Unifocus Claira is built for the needs of hospitality today and for the future, delivering the capabilities hoteliers actually need to strategically manage their business. The intuitive user experience and rapid onboarding process enables teams to get up and running quickly on the solution. AI is embedded throughout the platform, moving beyond reporting to provide practical, day-to-day recommendations, from optimizing schedules to supporting compliance to identifying when tasks should be reassigned. By turning operational data into actionable guidance, Unifocus Claira enables hospitality leaders to respond faster to changing business needs, improve performance and minimize operational risk.


For on-property teams, this means less time spent managing spreadsheets and disconnected systems, and more time focused on people and guest experience. With greater visibility into workforce costs, productivity and profitability, managers can make more informed decisions while creating a better experience for both employees and guests.


Above-property teams gain greater access to portfolio-level insights as they quickly view metrics through corporate dashboards, enabling them to proactively engage on-property teams, quickly address changing business needs, and ensure a high level of guest satisfaction and profitability.


“Hospitality leaders have never needed greater visibility into their people, operations and performance, yet many are still working across disconnected systems and data,” said John Lockyer, CEO of Unifocus. “Unifocus Claira changes that by simplifying hoteliers’ technology needs and bringing labor, operations, and AI together in one purpose-built platform. We’re putting intelligent, actionable insights directly into the hands of hospitality teams so they can make better decisions faster and ultimately gain more time to focus on what matters most - their people and their guests.”


Unifocus Claira redefines workforce management, now with a complete view across labor and operations. This marks a new chapter for hospitality technology, giving operators the tools and intelligence to keep pace with a rapidly evolving industry. For Select Service operators in particular, it represents a significant step towards a more connected, responsive and data-driven approach to running their businesses.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260915476684/en/



Permalink

https://www.aetoswire.com/en/news/1509202657340


Contacts

Media Contact

Anna Ransom

Vice President of Marketing, Unifocus

ARansom@unifocus.com

Quectel Announces Launch of Tarrius to Deliver Next-Generation Precision Positioning Solutions for Demanding Field Applications

MUNICH - Tuesday, 15. September 2026



(BUSINESS WIRE) -- Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the launch of Tarrius, a new precision technology solution focused on advancing spatial intelligence.


Operating across APAC, Latin America, EMEA and China, Tarrius combines advanced positioning technology and specialist industry expertise with Quectel’s global engineering, manufacturing, and service capabilities, to deliver dependable, high-accuracy solutions for demanding field applications including surveying and mapping, deformation monitoring and machine guidance. Tarrius combines precision positioning, reliable connectivity and efficient data transmission to enable more accurate, streamlined digital workflows in the field.


“Tarrius is built around a simple promise, a precision you can build on. We’re combining centimetre- to millimetre-level positioning with seamless connectivity and efficient data transmission to create dependable digital workflows for demanding surveying, monitoring and construction applications,” commented Windy Fang, GNSS Product Director, Quectel. “We can offer customers not just advanced technology, but a dependable long-term partner wherever they operate.”


Tarrius is launching with a broad portfolio of high-precision GNSS products for surveying and mapping, deformation monitoring and machine guidance that will be demonstrated at INTERGEO and will be commercially available in November 2026. The range includes GNSS receivers, reference stations, field controllers, monitoring and guidance receivers and high-precision antennas, alongside Tarrius software for managing field work, correction services and monitoring projects. Together, the portfolio gives customers the tools they need to collect, manage and use accurate positioning data throughout their day-to-day operations.


For surveying professionals, the compact TR10 combines visual AR stakeout with calibration-free tilt compensation and RTKHOLD technology, while the TR12 adds dual cameras and an integrated laser rangefinder for measurements in locations that are difficult or impractical to reach. The TR12B provides a dedicated base station option, with a built-in 5W UHF radio offering coverage of up to 15km and a rugged design for demanding field environments.


The portfolio also addresses permanent installations and specialist applications. The TR09N is designed for continuous operation as a GNSS reference station, combining full-constellation tracking with global 4G LTE connectivity and low power consumption. For deformation monitoring, the TR07M brings together millimetre-level positioning, automatic data collection and transmission, and cloud and edge processing, while the TR07B provides an integrated base station solution for distributing GNSS correction data. The range is completed by the TR05G, a heading and guidance receiver designed for machine control applications.


Tarrius will be showcasing its new product portfolio at INTERGEO in Munich at stand C6D102 on 15th – 17th September.


About Tarrius


Tarrius provides high-precision GNSS solutions backed by more than 15 years of expertise in positioning, wireless communications and IoT technology, supporting professionals who survey, map and shape the world around us.


Find out more www.tarrius.com or on our LinkedIn page.


About Quectel


Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global end-to-end IoT solutions provider backed by outstanding support and services.


With a worldwide team of over 8,900 professionals, we lead the way in delivering end-to-end IoT solutions, spanning cellular, GNSS, satellite, Wi-Fi and Bluetooth modules, high-performance antennas, value-added services and full turnkey offerings including ODM services and system integration.


With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.


For more information, please visit: www.quectel.com or LinkedIn


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260915860977/en/



Permalink

https://www.aetoswire.com/en/news/1509202657322


Contacts

Quectel

Media contact: media@quectel.com


Tarrius

Media contact: marketing@tarrius.com

Rimini Street and Datacom Announce Strategic Partnership to Accelerate AI Adoption and Drive IT Optimisation Across ANZ

 SYDNEY - Tuesday, 15. September 2026 AETOSWire Print 



Collaboration delivers expert third-party support for Oracle and SAP, keeping systems secure, compliant and stable for immediate Agentic AI ERP innovation while freeing up capital for growth and profitability


 


(BUSINESS WIRE)--Rimini Street Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle and SAP software, today announced a strategic partnership with Datacom, one of Australasia’s largest homegrown technology services and solutions providers. The reseller agreement will see Datacom offer Rimini Support™ for Oracle and SAP software to its public and private sector customers across Australia and New Zealand.


This collaboration brings together Rimini Street's third-party software support, trusted by thousands of leading organisations including Fortune Global 100, Fortune 500, midmarket, public sector and government agencies, with Datacom’s extensive market presence and implementation expertise. As part of its core platforms portfolio, Datacom will offer level 4 support services, security and compliance solutions, powered by Rimini Street, to its clients on perpetually licensed versions of Oracle and SAP software, without needing to upgrade or give up their licenses.


The partnership enables Datacom to offer a compelling value proposition: clients benefit from expert support services, significant savings on their enterprise software support of up to 90% of total costs and the ability to redirect IT budget and talent towards strategic initiatives such as digital transformation, cloud migration and AI-driven projects for greater competitive advantage and growth.


“This is a first-of-its-kind partnership for Rimini Street in this region, and we are excited to join forces with a technology leader like Datacom at a pivotal moment, when economic pressures and the urgency to accelerate AI adoption intersect,” said Shirley Riddick, GVP and regional GM, ANZ, Rimini Street. “Rimini Street and Datacom together can help organisations maximise the full value of their current investments, reduce operating risk and leapfrog innovation by deploying Agentic AI in weeks, not months, on top of their existing systems.”


“We are excited to partner with Rimini Street to enhance our service offerings. This partnership allows Datacom to provide our clients across ANZ with a proven solution that helps to extend the life and value of their enterprise software investments so they can continue on their AI journeys. It aligns perfectly with our commitment to helping customers solve their biggest challenges and achieve their strategic goals," said Dave Payne, director, Core Platforms, Australia and New Zealand, Datacom.


To learn more about partnering with Rimini Street visit riministreet.com/partners/.


About Rimini Street, Inc.


Rimini Street, Inc. (Nasdaq: RMNI), a Russell 2000® Company, is a proven, trusted global provider of end-to-end, mission-critical enterprise software support, managed services and innovative Agentic AI ERP solutions, and is the leading third-party support provider for Oracle and SAP software. The Company has signed thousands of IT service contracts with Fortune Global 100, Fortune 500, midmarket, public sector and government organisations who have leveraged the Rimini Smart Path™ methodology to achieve better operational outcomes, billions of US dollars in savings and fund AI and other innovation.


To learn more, please visit www.riministreet.com, and connect with Rimini Street on X, Facebook, Instagram, and LinkedIn.


About Datacom


Built on strong values, Datacom has grown to be one of the region's leading locally owned technology businesses. We work across Australia and New Zealand to make a difference in people's lives by turning the imaginable into reality. Datacom supports customers through a broad range of services and solutions that span technology, operations, digital services and products, all underpinned by robust industry experience and insight. With nearly 6,000 people working across Australia, New Zealand and Asia, Datacom is truly world-class in capability and proudly local at heart. For more information, visit www.datacom.com.


Forward-Looking Statements


Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “anticipate,” “assume,” “believe,” “budget,” “continue,” “could,” “currently,” “estimate,” “expect,” “forecast,” “future,” “intend,” “may,” “might,” “outlook,” “plan,” “possible,” “goal,” “potential,” “predict,” “project,” “reflect,” “results,” “seem,” “seek,” “should,” “will,” “would” and other similar words, phrases or expressions. These forward-looking statements include, but are not limited to, statements regarding our expectations of future events, future opportunities, global expansion and other growth initiatives and our investments in such initiatives. These statements are based on various assumptions and on the current expectations of management and are not predictions of actual performance, nor are these statements of historical facts. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to our ability to attract new clients or retain and/or sell additional products or services to existing clients; our ability to achieve and maintain an adequate rate of revenue growth; cost of revenue, including changes in costs associated with our efforts to grow and the results of any efforts to manage costs to align with current revenue expectations and the expansion of our offerings; the effects of increased intense competition in our industry and our ability to compete effectively; our ability to successfully educate the market regarding the advantages of our support and managed services for ERP software and to sell the products and services comprising our “Rimini Smart Path™” solutions portfolio, including but not limited to our Agentic AI ERP solutions; our intentions with respect to our pricing model and expectations of client savings relative to use of other providers; the evolution of the ERP software management and support landscape facing our clients and prospects; estimates of our total addressable market; the effects of seasonal trends on our results of operations, including the contract renewal cycles for vendor-supplied software support and managed services; the effects of the efforts of enterprise software vendors to sell upgrades or migrations to cloud-based versions of their enterprise software on our results of operations; our ability to scale our operations quickly enough to meet our clients’ changing needs or decrease our costs adequately in response to changing client demand; risks arising from incorporating artificial intelligence (“AI”) technologies into our products or services or any deficiencies associated with AI technologies used by us or by our third-party vendors and service providers; our ability to maintain, protect, and enhance our brand; the loss of one or more members of our management team and our ability to attract and retain additional qualified technical, sales and marketing personnel; our ability to expand our marketing and sales capabilities; our ability to avoid interruptions to, or degraded performance of, our services and the impact of any such interruptions or performance problems on our operations; our ability to defend against cybersecurity threats and to comply with data protection and privacy regulations; our expectations regarding new product offerings, innovation solutions, partnerships and alliance programs and our ability to develop and maintain strategic partnerships; our ability to expand internationally and the risks associated with global operations; our wind down of support services for Oracle’s PeopleSoft software products and the impact on future period revenue and costs incurred related to these efforts; the continuing impact of and our ability to comply with the terms of our July 2025 settlement agreement with Oracle; the impact of macro-economic trends, including inflation and changes in foreign exchange rates, as well as general financial, economic, regulatory and political conditions affecting the industry in which we operate and the industries in which our clients operate; our ability to generate significant capital through our operations or to raise additional capital necessary to fund and expand our operations and invest in new services and products; our business plan and our ability to effectively secure and manage our growth and associated investments; risks relating to retention rates, including our ability to accurately predict retention rates; our ability to protect our intellectual property; our ability to maintain an effective system of internal control over financial reporting; changes in laws or regulations, including tax laws or unfavorable outcomes of tax positions we take; tariff costs; our ability to realise benefits from our net operating losses; any negative impact of environmental, social and governance (“ESG”) matters on our reputation or business and the exposure of our business to additional costs or risks from our reporting on such matters; our credit facility’s ongoing debt service obligations and financial and operational covenants on our business and related interest rate risk; the sufficiency of our cash and cash equivalents to meet our liquidity requirements; the volatility of our stock price; the amount and timing of repurchases, if any, under our stock repurchase program and our ability to enhance stockholder value through such program; our ability to maintain our good standing with the United States and international governments and capture new contracts with public sector entities; the occurrence of catastrophic events that may disrupt our business or that of our current and prospective clients; future acquisitions of, or investments in, complementary companies, products, subscriptions or technologies; and those discussed under the heading “Risk Factors” in Rimini Street’s Quarterly Report on Form 10-Q filed on July 30, 2026, and as updated from time to time by Rimini Street’s future Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings by Rimini Street with the U.S. Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.


© 2026 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260914070894/en/



Permalink

https://www.aetoswire.com/en/news/1509202657314


Contacts

Janet Ravin

VP, Corporate Marketing

Rimini Street, Inc.

+1 702 285-3532

pr@riministreet.com

Kinaxis Advances Operational Orchestration Vision with Agentic AI at Kinexions EMEA 2026

 Global brands including Bosch, Castrol, Coca-Cola Al Ahlia Beverages, and Moët Hennessy take the stage in Barcelona as Kinaxis sets the direction for the next era of supply chain


 


(BUSINESS WIRE)--Kinaxis® Inc. (TSX:KXS), a global leader in AI-powered supply chain planning and orchestration, will bring together some of the world’s most innovative supply chain leaders at Kinexions EMEA 2026 from October 26-28. Building on the operational orchestration vision Kinaxis introduced earlier this year, the conference offers an inside look at how leading organizations are harnessing AI innovation and agentic capabilities to help supply chain leaders make better decisions, coordinate action across the business and drive measurable outcomes.


From AI Potential to Operational Impact


As organizations continue to invest heavily in AI, many struggle to translate intelligence into action - just 12% of supply chain leaders consider themselves AI leaders, despite widespread deployment of AI capabilities. Kinaxis CEO Razat Gaurav and Executive Vice President, EMEA, Fabienne Cêtre, will open the mainstage with an exploration of the market forces reshaping global supply chains and how operational orchestration is helping organizations bridge that gap by connecting people, processes, data, and AI across the enterprise. This welcome session will be livestreamed globally.


The mainstage program will offer a look at the technologies reshaping supply chain and how AI is evolving from a decision-support tool into an operational partner.


Andrew Bell, Chief Product Officer, will showcase what’s ahead for Kinaxis, including the continued evolution of Maestro and a closer look at how innovations in AI-powered orchestration will help supply chain teams respond faster and align decisions across functions.

Manik Sharma, Chief of Agentic Solutions, will build on this with a deeper look at how forward deployed engineering (FDE) teams are working alongside organizations to move agentic AI into real enterprise environments and accelerate measurable value.

“Supply chains are operating in an environment where the speed and complexity of decision-making have fundamentally changed,” said Razat Gaurav, CEO of Kinaxis. “AI is creating an entirely new frontier for supply chain, but technology alone doesn’t create business value. At Kinexions North America, we introduced our vision for operational orchestration to move from decisions to outcomes in a more connected way. Since then, we’ve been turning that vision into real capabilities for our customers and partners globally. In Barcelona, we’ll show attendees how it’s becoming a reality and what it means for the future of supply chain.”


Keynote: Human Performance in an AI-Powered World


Taking the stage as the featured keynote speaker is Dr. James Hewitt, human performance scientist, author, and expert on performance under pressure. Drawing on research spanning Formula 1 to Fortune 500 organizations, Hewitt will explore why human judgment and trust matter more as AI takes on greater autonomy. That balance between human judgment and intelligent technology will carry throughout the event as Kinaxis explores what an increasingly agentic world means for the future of the supply chain industry and its leaders.


Three Days of Insight, Innovation and Community


Attendees will hear directly from global leaders at Bosch, Castrol, Coca-Cola Al Ahlia Beverages, Moët Hennessy and more about how they are navigating complex global supply chains, volatility and changing business demands. Kinexions EMEA will offer dedicated product showcases, expert-led sessions and hands-on bootcamps to move the conversation from concept to experience, giving attendees the opportunity to explore the technologies and approaches behind Kinaxis' vision for operational orchestration. The program will also offer opportunities to connect with partners and peers, along with the Women in Supply Chain Breakfast, a dedicated forum for leadership and celebrating the women helping to move the industry forward.


Kinexions EMEA 2026 takes place October 26–28 at the Grand Hyatt Barcelona.


View the agenda HERE

Registration is open HERE


About Kinaxis


Kinaxis is a leader in modern supply chain planning and orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.


Source: Kinaxis Inc.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260915788515/en/



Permalink

https://www.aetoswire.com/en/news/1509202657330


Contacts

Media Relations

Erin Boyle | Kinaxis

eboyle@kinaxis.com

+1 519-574-4065


Investor Relations

Victoria Hyde-Dunn | Kinaxis

vhyde-dunn@kinaxis.com